US Drug Regulator Delays Novavax Covid Vaccine Approval [Barron's]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Barrons
In a document sent to the financial markets regulator and seen by AFP, US drugmaker Novavax said it was still awaiting a response from the Food and Drug Administration (FDA), which had been promised to make a decision by April 1. "As of Tuesday, April 1, we had responded to all of the FDA's information requests," Novavax said in the filing, adding it believes its vaccine is ready for approval. "As of today, we continue to wait on action from the agency and have not yet received an official decision from the US FDA," it added. The company is seeking full approval of its Covid-19 vaccine, which is already authorized in the United States through an emergency use procedure for people aged 12 and over. According to the Wall Street Journal, which first rep
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- RFK Jr. Responds To Report He's Considering Removing COVID-19 Vaccines From CDC Schedule [zero hedge]zero hedge
- How Will RFK’s Cuts At The CDC, FDA And NIH Affect You? [Forbes]Forbes
- Novavax says its COVID-19 shot is on track for full FDA approval after delay [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novavax jumps after FDA asks for more data on its Covid vaccine [Yahoo! Finance]Yahoo! Finance
- SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/27/25 - Beat
NVAX
Sec Filings
- 4/23/25 - Form 8-K
- 4/14/25 - Form 144
- 4/2/25 - Form 8-K
- NVAX's page on the SEC website